We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Homocysteine and mild cognitive impairment: Are these the tools for early intervention in the dementia spectrum?
- Authors
Ansari, Zarrin
- Abstract
Dementia, being a neurodegenerative disease, has devastating consequences not just for the ailing but also for the carers as it has a tremendous negative impact on the quality of life. The pathophysiology of dementia commences far earlier than its diagnosis. Mild cognitive impairment (MCI) is a stage prior to definite dementia. The progression from MCI to dementia is insidious with no definite demarcation, thus making diagnosis clinically difficult at an early stage. This paper attempts to throw light on the epidemiology, risk factors and the aetiopathogenesis of MCI. It further attempts to elaborate on the rate of conversion of MCI to definite dementia and the factors influencing the same. Many established as well as probable, modifiable as well as non-modifiable risk factors influence the progress of MCI to definite dementia. Homocysteine, a sulphur containing amino-acid has been identified as a probable risk factor for the dementia spectrum. Various existing clinical evidences and biological plausibility towards probable link between homocysteine and dementia are discussed in this paper. B vitamin mediated homocysteine reduction and cognitive outcomes demonstrate mixed results. This review attempts to evaluate hyperhomocysteinaemia and MCI as a brain risk marker and assess their potential for future research with a view to attempt early intervention.
- Subjects
BIOMARKERS; COGNITION disorders; DEMENTIA; RISK assessment; SYSTEMATIC reviews; HYPERHOMOCYSTEINEMIA
- Publication
Journal of Nutrition, Health & Aging, 2016, Vol 20, Issue 2, p155
- ISSN
1279-7707
- Publication type
Article
- DOI
10.1007/s12603-015-0576-y